Recently, TYK Medicines received the certificate of consent for the establishment of the Zhejiang Postdoctoral Workstation from the Zhejiang Province Postdoctoral Affairs Office.

Currently, the Postdoctoral Research Station engaged its first postdoctoral fellow. The research project is mainly for the research, development, and industrialization of world-class targeted antitumor innovative drugs. More postdoctoral fellows shall be introduced in the later stage with the company’s business development needs. The approval of the Postdoctoral Workstation is also an important milestone of the company’s innovative R&D and talent cultivation, which is of great significance to the development of the company. The Postdoctoral Workstation is an important platform for cultivating and introducing high-end talents, and an effective carrier for promoting the combination of industry, academia, and research, which provides strong talent support for the high-quality development of the company. The company will spare no effort to continue to promote the construction of postdoctoral workstation inductees, through the close combination of theory and practice, to stimulate the enthusiasm of innovation of scientific researchers, to carry out cutting-edge technology research, to lead the development of industry, and to contribute their own strength to “Intelligently manufacturing in China”.